Latest news with #LargeCap
Yahoo
05-08-2025
- Business
- Yahoo
Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates
Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +34.48%. A quarter ago, it was expected that this drugmaker would post earnings of $0.64 per share when it actually produced earnings of $0.92, delivering a surprise of +43.75%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Pfizer, which belongs to the Zacks Large Cap Pharmaceuticals industry, posted revenues of $14.65 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 6.35%. This compares to year-ago revenues of $13.28 billion. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Pfizer shares have lost about 11.3% since the beginning of the year versus the S&P 500's gain of 7.6%. What's Next for Pfizer? While Pfizer has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Pfizer was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.86 on $17.37 billion in revenues for the coming quarter and $3.07 on $63.4 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Large Cap Pharmaceuticals is currently in the top 37% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, Eli Lilly (LLY), is yet to report results for the quarter ended June 2025. The results are expected to be released on August 7. This drugmaker is expected to post quarterly earnings of $5.61 per share in its upcoming report, which represents a year-over-year change of +43.1%. The consensus EPS estimate for the quarter has been revised 1.5% lower over the last 30 days to the current level. Eli Lilly's revenues are expected to be $14.75 billion, up 30.5% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Pfizer Inc. (PFE) : Free Stock Analysis Report Eli Lilly and Company (LLY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-07-2025
- Business
- Yahoo
Faith-Based Firm Led by Bob Doll Adds First ETFs
Bob Doll's latest mark on the religious-values firm Crossmark Global Investments is the introduction of two ETFs, the first such products that firm has offered in the wrapper. Last week, the company launched its Crossmark Large Cap Growth and Large Cap Value ETFs, both of which are copies of strategies in separately managed accounts that Doll, the CEO, added to the company when he started there four years ago. The funds invest in Russell 1000 companies, excluding those involved in alcohol, tobacco, abortions, stem-cell research, adult entertainment or cannabis. The corresponding SMAs have beaten their benchmarks and have pulled in new money, reaching a combined total of about $700 million. But, as Doll said he told his company, 'we can be a firm if we don't have ETFs — but if we really want to thrive we need ETFs.' READ ALSO: What Coca-Cola's New Sugar-Cane Coke Means for a Sugar ETF and Why the SEC Keeps Putting Off Diversified Crypto ETFs Spreading the Gospel About two-thirds of Crossmark's assets are in portfolios with religious values screens, Doll said. 'We're very broad-based. Our goal is to avoid products that are designed to maim or kill people,' he told ETF Upside. The firm could eventually have six to eight ETFs in its lineup, he noted. While there are more than 40 US ETFs with Christian or Sharia-compliant investment strategies, financial advisors said there is room for more products: Invest in Gold American Hartford Gold: #1 Precious Metals Dealer in the Nation Priority Gold: Up to $15k in Free Silver + Zero Account Fees on Qualifying Purchase Thor Metals Group: Best Overall Gold IRA 'The number of religious-specific ETFs is still rather low, resulting in ETFs that are built for a broader client base,' said Omen Quelvog, founder of Formynder Wealth Management. 'The difficulty there is the number of holdings that could still cause a conflict.' 'Some are solid, but many are too generic and often don't show clearly what's inside them. That lack of clarity doesn't work for values-based families who want more intention behind their investments,' said Daniel Goodman, founder of Good Better Best Financial Planning. 'That's why I often use direct indexing.' Branches and Denominations: Crossmark and others provide a range of strategies to reflect nuances in faith, though it can be difficult to offer something for everyone. 'As a Catholic myself, I appreciate the attempt to create religious ETFs,' said Alvin Carlos, managing partner of District Capital Management. 'But I am skeptical about whether one can truly reflect one's religious beliefs. There are so many angles to consider.' This post first appeared on The Daily Upside. To receive exclusive news and analysis of the rapidly evolving ETF landscape, built for advisors and capital allocators, subscribe to our free ETF Upside newsletter. Sign in to access your portfolio
Yahoo
28-07-2025
- Business
- Yahoo
Simon Property Group Inc: A Significant Exit by Parnassus Value Equity Fund
Exploring the Strategic Moves in the Second Quarter of 2025 Introduction to Parnassus Value Equity Fund (Trades, Portfolio) Warning! GuruFocus has detected 7 Warning Sign with DE. Parnassus Value Equity Fund (Trades, Portfolio) recently submitted its N-PORT filing for the second quarter of 2025, shedding light on its strategic investment decisions during this period. As part of Jerome Dodson (Trades, Portfolio)s Parnassus Investments, the fund is known for its fossil-fuel-free and positive workplace investment philosophy, focusing on deeply discounted, out-of-favor stocks with a wide range of expected outcomes. Although Mr. Dodson stepped back from fund management at the end of 2020, Billy Hwan has since taken the helm as the portfolio manager. In mid-2021, Affiliated Managers Group acquired a majority stake in Parnassus, gaining control of the firm. The fund, previously known as the Parnassus Endeavor Fund, was renamed on December 30, 2022. It primarily invests in U.S. large-cap companies with long-term competitive advantages, quality management, and strong ESG performance, while avoiding fossil fuel investments. Summary of New Buy Parnassus Value Equity Fund (Trades, Portfolio) added a total of six stocks, including: The most significant addition was Willis Towers Watson PLC (NASDAQ:WTW), with 340,315 shares, accounting for 2.3% of the portfolio and a total value of $104.31 million. The second largest addition to the portfolio was Linde PLC (NASDAQ:LIN), consisting of 172,806 shares, representing approximately 1.79% of the portfolio, with a total value of $81.08 million. The third largest addition was Thermo Fisher Scientific Inc (NYSE:TMO), with 192,274 shares, accounting for 1.72% of the portfolio and a total value of $77.96 million. Key Position Increases Parnassus Value Equity Fund (Trades, Portfolio) also increased stakes in a total of 15 stocks, including: The most notable increase was in JPMorgan Chase & Co (NYSE:JPM), with an additional 144,227 shares, bringing the total to 518,049 shares. This adjustment represents a significant 38.58% increase in share count, a 0.92% impact on the current portfolio, and a total value of $150.19 million. The second largest increase was in Alphabet Inc (NASDAQ:GOOGL), with an additional 138,991 shares, bringing the total to 700,500. This adjustment represents a significant 24.75% increase in share count, with a total value of $123.45 million. Summary of Sold Out Parnassus Value Equity Fund (Trades, Portfolio) completely exited six holdings in the second quarter of 2025, including: Simon Property Group Inc (NYSE:SPG): The fund sold all 670,528 shares, resulting in a -2.49% impact on the portfolio. Pfizer Inc (NYSE:PFE): The fund liquidated all 4,390,705 shares, causing a -2.48% impact on the portfolio. Key Position Reduces Parnassus Value Equity Fund (Trades, Portfolio) also reduced positions in 23 stocks. The most significant changes include: Reduced Micron Technology Inc (NASDAQ:MU) by 441,765 shares, resulting in a -45.26% decrease in shares and a -0.86% impact on the portfolio. The stock traded at an average price of $93.31 during the quarter and has returned 41.30% over the past three months and 32.07% year-to-date. Reduced Sysco Corp (NYSE:SYY) by 479,388 shares, resulting in a -23.49% reduction in shares and a -0.8% impact on the portfolio. The stock traded at an average price of $72.65 during the quarter and has returned 15.57% over the past three months and 7.89% year-to-date. Portfolio Overview At the end of the second quarter of 2025, Parnassus Value Equity Fund (Trades, Portfolio)'s portfolio included 45 stocks. The top holdings included 3.74% in Deere & Co (NYSE:DE), 3.72% in S&P Global Inc (NYSE:SPGI), 3.37% in Bank of America Corp (NYSE:BAC), 3.33% in CBRE Group Inc (NYSE:CBRE), and 3.31% in JPMorgan Chase & Co (NYSE:JPM). The holdings are mainly concentrated in 10 of the 11 industries: Financial Services, Technology, Healthcare, Industrials, Consumer Cyclical, Communication Services, Consumer Defensive, Real Estate, Utilities, and Basic Materials. This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
28-07-2025
- Business
- Yahoo
1 Large-Cap Stock to Research Further and 2 We Ignore
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task. These trade-offs can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you find high-quality companies that can grow their earnings no matter what. Keeping that in mind, here is one large-cap stock that still has big upside potential and two whose existing offerings may be tapped out. Two Large-Cap Stocks to Sell: Take-Two (TTWO) Market Cap: $41.1 billion Best known for its Grand Theft Auto and NBA 2K franchises, Take Two (NASDAQ:TTWO) is one of the world's largest video game publishers. Why Is TTWO Not Exciting? EBITDA margin fell by 8.3 percentage points over the last few years as it prioritized growth over profits Incremental sales over the last three years were much less profitable as its earnings per share fell by 108% annually while its revenue grew Increased cash burn over the last few years raises questions about the return timeline for its investments Take-Two's stock price of $224.74 implies a valuation ratio of 19x forward EV/EBITDA. Check out our free in-depth research report to learn more about why TTWO doesn't pass our bar. IQVIA (IQV) Market Cap: $33.86 billion Created from the 2016 merger of Quintiles (a clinical research organization) and IMS Health (a healthcare data specialist), IQVIA (NYSE:IQV) provides clinical research services, data analytics, and technology solutions to help pharmaceutical companies develop and market medications more effectively. Why Does IQV Fall Short? Annual sales growth of 3.4% over the last two years lagged behind its healthcare peers as its large revenue base made it difficult to generate incremental demand Weak constant currency growth over the past two years indicates challenges in maintaining its market share Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.5 percentage points At $198.90 per share, IQVIA trades at 16.1x forward P/E. If you're considering IQV for your portfolio, see our FREE research report to learn more. One Large-Cap Stock to Watch: Zscaler (ZS) Market Cap: $44.56 billion After successfully selling all four of his previous cybersecurity companies, Jay Chaudhry's fifth venture, Zscaler (NASDAQ:ZS) offers software-as-a-service that helps companies securely connect to applications and networks in the cloud. Why Are We Fans of ZS? Customers view its software as mission-critical to their operations as its ARR has averaged 24.3% growth over the last year Sales outlook for the upcoming 12 months implies the business will stay on its desirable three-year growth trajectory ZS is a free cash flow machine with the flexibility to invest in growth initiatives or return capital to shareholders Zscaler is trading at $286.80 per share, or 14.5x forward price-to-sales. Is now the right time to buy? See for yourself in our comprehensive research report, it's free. High-Quality Stocks for All Market Conditions When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that's already erased most losses. Don't let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today for free. StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
Yahoo
23-07-2025
- Business
- Yahoo
The Nasdaq Just Reached a New All-Time High -- These ETFs Could Keep Climbing
Key Points If you're looking to beat the market, investing in top artificial intelligence (AI) stocks is a no-brainer. The Fundstrat Granny Shots U.S. Large Cap ETF offers diversified exposure to multiple investing themes, including AI. The Dan Ives Wedbush AI Revolution ETF is perfect for investors who want instant diversification across all the key players. 10 stocks we like better than Tidal Trust III - Fundstrat Granny Shots Us Large Cap ETF › The Nasdaq Composite (NASDAQINDEX: ^IXIC) recently broke through the 20,000 point level to reach new highs. Investors who feel overwhelmed about picking their own stocks shouldn't fret. The beauty of exchange-traded funds (ETFs) is that they can be used to achieve targeted exposure to almost any theme, or investment strategy, you're interested in. Investors shouldn't overthink this. There is one obvious opportunity in 2025 to beat the market -- artificial intelligence (AI). The market rally continues to be fueled by companies enabling the adoption of this technology, so focusing on top ETFs that offer adequate exposure to this opportunity is your best bet. Here are two I would buy right now. 1. Fundstrat Granny Shots U.S. Large Cap ETF Don't be fooled by the name. If you're looking for a fund that seeks to hold shares of industry leaders across emerging trends in the economy, not just AI, this fund is for you. The Fundstrat Granny Shots U.S. Large Cap ETF (NYSEMKT: GRNY) is an actively managed fund that just launched last year. The fund is led by Tom Lee, who is head of research at Fundstrat Capital. Lee previously served as JPMorgan Chase's Chief Equity Strategist from 2007 through 2014, when Lee co-founded Fundstrat Global Advisors. Since its inception in 2024, the Granny Shots ETF is up 14.9% compared to the Nasdaq's 8.4% return at the time of writing. Lee and his team use a top-down method of selecting stocks. This means they identify key themes that are breeding opportunities, such as AI or fintech, and then select the best stocks to capitalize on those themes. In addition to AI, the long-term themes reflected in the fund's stock holdings are millennials' increasing spending power, energy, cyber security, and improving economic conditions. These themes can change based on Fundstrat's research but this is what it is currently working with to select stocks for the fund. Here's a quick look at the top 10 holdings in the fund as of July 17, and their respective weightings: Robinhood Markets (3.91%) Oracle (3.55%) Advanced Micro Devices (3.40%) Nvidia (3.13%) GE Vernova (3.03%) GE Aerospace (2.85%) Palantir Technologies (2.79%) KLA Corp. (2.79%) Goldman Sachs (2.76%) Caterpillar (2.76%) One thing that might appeal to investors is that it's not going after just one trend like AI. Lee is thinking broadly about all the key trends in the economy and structuring the portfolio to profit from them. It's worth mentioning that Lee is a regular guest on CNBC, which is beneficial for investors. If you decide to invest in the fund, there are plenty of videos of Lee's interviews on YouTube or X to get insight into his strategy and thinking. The fund charges an expense ratio of 0.75%, which is typical for an actively managed ETF. This means for every $1,000 invested, you will incur an annual cost of $7.50. Since this is a relatively new ETF, investors should start with a small position and average into it over time. After all, past performance isn't a guarantee of future results. But given the fund's focus on investing in industry-leading companies that have excellent growth prospects, this is a very promising ETF to consider holding for the long term. 2. Dan Ives Wedbush AI Revolution ETF Finally, for investors who want pure exposure to AI, look no further than a fund named after the biggest AI bull on Wall Street, Dan Ives. Ives is managing director and global head of technology research at Wedbush Securities. He's been covering the tech sector for many years as an analyst. The Dan Ives Wedbush AI Revolution ETF (NYSEMKT: IVES) includes the top stocks from Ives' coverage universe to profit off this opportunity. There are 30 holdings in the fund as of July 16. Here are current top 10 holdings and their respective weightings: Nvidia (5.62%) Oracle (5.28%) Taiwan Semiconductor Manufacturing (5.20%) Broadcom (4.92%) Microsoft (4.89%) Amazon (4.72%) Advanced Micro Devices (4.71%) Meta Platforms (4.64%) Apple (4.63%) Alphabet (4.50%) Keep in mind, this fund just launched over a month ago, so it doesn't have much of a track record. But it's not difficult to tell by looking at the holdings in the fund that it is likely to perform well. It's likely to outperform the Nasdaq over the next five years, at least. The fund has already attracted $343 million in assets since June 3, which reflects Ives' reputation as an analyst and the quality of the stocks in the portfolio. The fund is not actively managed but charges an expense ratio of 0.75%. But so far, the fund is up 9.3% since inception in June, slightly outpacing the Nasdaq at the time of this writing. The Fundstrat and Wedbush ETFs are likely to outperform the market over the next five years. While they will likely be more volatile than the major market indexes given their exposure to high-growth stocks, these growth ETFs are great choices for investors looking for a hands-off way to invest in the best growth stocks out there. Do the experts think Tidal Trust III - Fundstrat Granny Shots Us Large Cap ETF is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Tidal Trust III - Fundstrat Granny Shots Us Large Cap ETF make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,055% vs. just 180% for the S&P — that is beating the market by 874.27%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $665,092!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,050,477!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. JPMorgan Chase is an advertising partner of Motley Fool Money. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. John Ballard has positions in Advanced Micro Devices and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Alphabet, Amazon, Apple, Goldman Sachs Group, JPMorgan Chase, Meta Platforms, Microsoft, Nvidia, Oracle, Palantir Technologies, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom, GE Aerospace, and Ge Vernova and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. The Nasdaq Just Reached a New All-Time High -- These ETFs Could Keep Climbing was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
